Health Care & Life Sciences » Biotechnology | D. Western Therapeutics Institute Inc.

D. Western Therapeutics Institute Inc. | Balance Sheet

Fiscal year is January-December. All values JPY Millions.
2013
2014
2015
2016
2017
Cash & Short Term Investments
2,266
2,067
1,930
2,645
2,133
Total Accounts Receivable
-
-
23
41
61
Inventories
-
4
-
58
46
Other Current Assets
12
37
72
32
275
Total Current Assets
2,278
2,109
2,025
2,776
2,516
Net Property, Plant & Equipment
5
6
5
25
15
Total Investments and Advances
-
12
100
101
11
Intangible Assets
-
-
1
1
330
Other Assets
9
9
9
9
5
Total Assets
2,292
2,136
2,140
2,913
2,877
Accounts Payable
9
-
-
-
-
Income Tax Payable
8
6
6
13
19
Other Current Liabilities
5
14
22
23
137
Total Current Liabilities
23
19
27
36
156
Long-Term Debt
-
-
-
-
600
Other Liabilities
-
-
-
-
25
Total Liabilities
23
19
27
36
782
Common Equity (Total)
2,269
2,116
1,917
2,738
2,001
Total Shareholders' Equity
2,269
2,116
1,917
2,738
2,001
Total Equity
2,269
2,116
2,113
2,877
2,096
Liabilities & Shareholders' Equity
2,292
2,136
2,140
2,913
2,877
Accumulated Minority Interest
-
-
196
139
95

About D. Western Therapeutics Institute

View Profile
Address
CK21 Hirokoji-Fushimi Building, 7/F
Nagoya Aichi 460
Japan
Employees -
Website http://www.dwti.co.jp
Updated 09/14/2018
D. Western Therapeutics Institute, Inc. engages in the research and development of pharmaceutical drugs. Its products include ophthalmic solution and agents for anti-platelet and anti-glaucoma.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.